• NEWS & PUBLICATIONS
  • News and Media
  • Newsletters
  • Journals
  • Books
• MEMBERSHIP
  • Join/Renew
  • Benefits
  • Categories
  • Download a Member Application
  • Grants, Awards, and Scholarships
  • Access the Phantom Analysis Toolkit
  • Membership Directory
  • Chapters
  • Centers of Excellence
  • Councils
  • Member Spotlight
  • Women in Nuclear Medicine
  • SNMMI Fellow
  • Council and Center Internships
• EDUCATION
  • 2022 Annual Meeting Call for Abstracts
  • Webinars
• MEETINGS & EVENTS
  • Calendar of Events
  • Webinars
  • 2022 Mid-Winter Meeting
  • 2022 Therapeutics Conference
  • 2022 Annual Meeting
  • Nuclear Medicine & Molecular Imaging Week
• ADVOCACY
  • Coding & Reimbursement
  • Legislative Efforts
  • Government Relations News
  • Radiopharmaceutical Supply News
  • USP 825
  • Technologist State Issues
  • Position Statements
  • Coalition for PET Drugs
  • FDA PET Drug Manufacturing Q&A
• EVIDENCE & QUALITY
  • Clinical Guidelines and AUC
  • Quality
  • Practice Resources
  • Dose Optimization
  • About Quality & Practice
  • Dosimetry
• RESEARCH
  • Clinical Trials Network
  • Radiopharmaceutical Therapy Central
  • Preclinical Imaging
  • Nuclear Medicine Clinical Trial Group, LLC
  • Research: Learn More
• ABOUT SNMMI
  • Strategic Plan
  • Bylaws & Procedures
  • Governance - SNMMI
  • Governance - SNMMI-TS
  • History
  • Grants, Awards, and Scholarships
  • Career Center
  • About Nuclear Medicine & Molecular Imaging
  • International Collaboration
  • Outreach
  • Support SNMMI
  • Contact Us

CTN Newsletter: Pathways

• Jun 1, 2021 — Pathways June 2021 (Volume 11, Issue 2)

  Value Initiative: Research and Discovery Domain

• Jan 1, 2021 — Pathways January 2021 (Volume 11, Issue 1)

  Molecular Imaging 2020: Year in Review

• Jun 1, 2020 — Pathways June 2020 (Volume 10, Issue 2)

  Increasing Patient Volume in PET: Are You Ready?

• Jan 1, 2020 — Pathways January 2020 (Volume 10, Issue 1)

  Theranostics: Now and in the Future

• Jun 1, 2019 — Pathways June 2019 (Volume 9, Issue 2)

  FES PET: Headed Toward the Clinic?

• Jan 1, 2019 — Pathways January 2019 (Volume 9, Issue 1)

  18F Flurpiridaz Shows Promise as a Diagnostic Imaging Agent for CAD

• Jun 1, 2018 — Pathways June 2018 (Volume 8, Issue 2)

  Clinical Trials Network Launching PET Phantom Program for Compliance with New Joint Commission Requirements

• Jan 1, 2018 — Pathways January 2018 (Volume 8, Issue 1)

  The Promise of Lu-177-based Radiotherapies

• Jun 1, 2017 — Pathways June 2017 (Volume 7, Issue 2)

  68Ga-PSMA-11 PET/CT Clinical Trial Underway

• Jan 1, 2017 — Pathways January 2017 (Volume 7, Issue 1)

  Two New PET Imaging Agents Approved

• Jun 1, 2016 — Pathways June 2016 (Volume 6, Issue 2)

  PET Imaging of Immunotherapy

• Jan 1, 2016 — Pathways January 2016 (Volume 6, Issue 1)

  CTN Provides Academic CRO Services

• Jun 1, 2015 — Pathways June 2015 (Volume 5, Issue 2)

  The CTN Oncology Phantom Program: Evaluating 6 Years of Scanner Performance Data

• Jan 1, 2015 — Pathways January 2015 (Volume 5, Issue 1)

  PET in Prostate Cancer: A Focus on C-11 Choline

• Jun 1, 2014 — Pathways June 2014 (Volume 4, Issue 2)

  The Dawn of in vivo Tau Imaging

• Jan 1, 2014 — Pathways January 2014 (Volume 4, Issue 1)

  68Ga PET/CT Advances in the United States: A Personal Journey

• Jun 1, 2013 — Pathways June 2013

  The DOTA Discussion: TOC, TATE and NOC

• Jan 1, 2013 — Pathways January 2013

  Do You Need an IND?

• May 1, 2011 — Pathways May 2011

  FDA New Rule for cGMP: Updates for Radiopharmaceutical Manufacturers

• Sep 1, 2010 — Pathways September 2010

  The Radiotracer Approval Bottleneck: Improving the Flow through the Pipeline

• May 1, 2010 — Pathways May 2010

  Siemens Demonstration Project on Scanner Validation for FLT Multicenter Study

• Jan 1, 2010 — Pathways January 2010

  State of the Network